Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 0 $ 0
Costs and Operating Expenses    
Cost of revenue, excluding depreciation 0 0
Research and development expenses, excluding depreciation 82,487 39,319
Selling, general and administrative expenses, excluding depreciation 55,621 55,627
Depreciation 2,678 2,124
Total costs and operating expenses 140,786 97,070
Loss from operations (140,786) (97,070)
Other (expense) income    
Interest (expense) income (29) 11
Gain on fair value change in contingent earnout shares liability 15,465 83,560
Loss on fair value change in private placement warrants liability 0 (1,639)
Other (expense), net (17) (89)
Loss before income taxes (125,367) (15,227)
Provision for income taxes 0 0
Net loss and comprehensive loss $ (125,367) $ (15,227)
Per Share Data:    
Net loss per share, basic (in dollars per share) $ (0.54) $ (0.07)
Net loss per share, diluted (in dollars per share) $ (0.54) $ (0.07)
Weighted-average shares outstanding, basic (in shares) 233,661 224,795
Weighted-average shares outstanding, diluted (in shares) 233,661 224,795